(Date:11/21/2008)...all/ -- Heska Corporation,(Nasdaq: HSKA ) today... of,Security Analysts, 12th Annual Biotech and Sp...1177 Avenue of the Americas, 2nd Floor in New York...:35 a.m. Eastern Time (7:35 a.m.,Mountain Time) a...weeks,following the presentation through a link u...
(Date:11/21/2008)...ique to combat cancer, study says, , ,...archers have discovered that some cancer cells use...ight lead to new treatments that starve and kill t...ells in the body need to produce energy. They do t...uires oxygen. Compared with normal cells, tumor ce...
(Date:11/21/2008)...ire/ -- U.S. News & World Report and the Natio...BlueChoice(R) HealthPlan of South Carolina in the ...ished in U.S. News & World Report,s issue this...ks the nation,s best health plans based on clinica...ion scores. NCQA and U.S. News & World Report ...
(Date:11/21/2008)...production of neural stem cells , , FRID...mice, exercise appears to reverse the decline in t...h aging, Taiwanese researchers report. , This r...ave off aging appears to be due to exercise,s abil...or the production of new brain cells. , "As we...
Breaking Medicine News(10 mins):Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:Exercise Keeps the Brain Young 2(Date:11/20/2008)...N, Nov. 20 PAREXEL Inter...global biopharmaceutical services provider, today ...ru to provide regulatory consulting and clinical r...u office, PAREXEL now has locations throughout fiv...rica, which also include Argentina, Brazil, Chile,...
(Date:11/19/2008)... , Study did not achieve statistical significa...FirstCall/ -- Pharmos Corporation (Nasdaq: PARS ...al trial of its topical NanoEmulsion (NE) drug del...thanolamine. , , The multi-center, randomiz...ated the safety and efficacy of the Company,s 3% D...
(Date:11/19/2008)...gers $5 Million Payment from Roche- , , MON...ory Pharmaceuticals Corp. (Nasdaq: MEMY ) today ... for its Phase 2 trial of R3487/MEM 3454, its lead...impairment associated with schizophrenia (CIAS). ...se 2 trial, triggering a $5.0 million payment from...
(Date:11/18/2008)...OWNE, Va., Nov. 18 Fort...hered at a November national forum to consider cut...blic health and national economy from outbreaks of...unced today. , , Among those innovations: ,...y American kitchen table that detects highly conta...
Breaking Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Chrysler Goes Holistic to Revolutionize Back Pain Care in the Workplace 11973 1Chrysler Goes Holistic to Revolutionize Back Pain Care in the Workplace 11973 2Chrysler Goes Holistic to Revolutionize Back Pain Care in the Workplace 11973 3New study shows extent of harmful human influences on global ecosystems 11971 1New study shows extent of harmful human influences on global ecosystems 11971 2Cell phone cancer link found by Tel Aviv University scientist 11969 1Cell phone cancer link found by Tel Aviv University scientist 11969 2Choking Game Turned Deadly for 82 Youths 11967 1Choking Game Turned Deadly for 82 Youths 11967 2Choking Game Turned Deadly for 82 Youths 11967 3...un 4, 2007 - Pfizer announced today that,axitinib ...hibitor,of VEGFR 1, 2,3 (vascular endothelial grow...bine showed a trend towards prolonged,overall surv...cer,compared with gemcitabine alone, according to...., These data were presented at the 43rd American ...
...resented at ASCO confirm safety findings,and demon...ts with,colorectal and other types of cancer., PRI...r,Pharmaceuticals announced positive safety and ef...inotecan HCI:Floxuridine), Liposome,Injection in p...umors. Results were presented yesterday in a poste...
Other Medicine Technology:New Data Show Pfizer's Axitinib Prolonged Overall Survival in,Advanced Pancreatic Cancer When Combined with Standard of Care,Chemotherapy 2New Data Show Pfizer's Axitinib Prolonged Overall Survival in,Advanced Pancreatic Cancer When Combined with Standard of Care,Chemotherapy 3New Data Show Pfizer's Axitinib Prolonged Overall Survival in,Advanced Pancreatic Cancer When Combined with Standard of Care,Chemotherapy 4Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer,Patients Treated with Therapy Based on Ratiometric Dosing 2Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer,Patients Treated with Therapy Based on Ratiometric Dosing 3ACL 1000 is an affordable solution for low volume workloads, or as a backup analyzer. The test menu includes a variety of clotting assays, such as Lupus and APCR-V Leiden. The ACL 1000 also offers ba
The SYNCHRON CX4-S system consolidates DATs, TDMs and other esoteric tests in one workstation, targeted to the mid-size lab that processes 50-200 samples per day. Like all SYNCHRON CX super systems,
It takes powerful technology to increase laboratory efficiency and worker safety, and still lower costs. It takes the new SYNCHRON LX20 PRO, offering features that you will not find on any other chem
The leading fully automated system for plasma protein determinations. Third generation nephelometer combines reliability with highly cost-effective performance.
Medicine Products: